SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Board Changes

18 Feb 2022 07:00

RNS Number : 0610C
McBride PLC
18 February 2022
 

18 February 2022

 

McBride plc

 

Board Changes

 

McBride plc ("McBride" or the "Company") announces the appointment of Regi Aalstad as a Non-Executive Director with effect from 14 March 2022.

 

Regi has extensive leadership experience in global fast moving consumer goods. She has held Regional General Manager and Vice President positions with Procter & Gamble in Europe, Asia, Middle East and Africa. Regi is a Non-Executive Director at Ontex Group NV and in several tech start-ups. She also works as an advisor to Private Equity and to global strategy consultancies. Regi holds a Master of Business Administration from the University of Michigan, USA.

 

She previously held Non-Executive Director positions at Telenor ASA, and Geberit AG and was the Chair of an international NGO.

 

Regi will serve as a member of the Nomination, Remuneration and Audit & Risk Committees. Regi's appointment satisfies the requirements of Provision 24 of the UK Corporate Governance Code.

 

Steve Hannam, Senior Independent Non-executive Director, having served nine years, will be stepping down from the Board immediately following the annual general meeting on 18th October 2022. Succession planning for his role as Senior Independent Director is underway and at the end of this process we should be in a position to release further information regarding the appointment of a new Senior Independent Director.

 

Jeff Nodland, Chairman of McBride commented:

 

"Regi brings extensive experience from the global fast moving consumer goods market. Her knowledge of the Asian and European markets, along with her strong board experience will be extremely beneficial to the Board. We are delighted to welcome Regi to McBride.

 

I would like to take the opportunity to thank Steve for his wise counsel and guidance over the last nine years. Steve's insight and contribution to Board discussions have been invaluable to the Board and the business, from which we will continue to benefit until the AGM. I wish him the very best for the future."

 

McBride has been notified that there are no further details to be disclosed in respect of Regi Aalstad pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority and this announcement is made in accordance with Listing Rule 9.6.11.

 

 

 

McBride plc

 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFLFITFVIDLIF
Date   Source Headline
5th Jan 20157:00 amRNSTrading Update
18th Dec 20147:00 amRNSBoard Changes
1st Dec 20145:04 pmRNSIssue of B Shares
21st Nov 20149:12 amRNSHolding(s) in Company
11th Nov 201412:46 pmRNSHolding(s) in Company
21st Oct 201410:25 amRNSResult of AGM
20th Oct 20144:08 pmRNSAppointment of Chief Finance Officer
20th Oct 20147:00 amRNSAGM and Interim Management Statement
29th Sep 201412:56 pmRNSDirector/PDMR Shareholding
19th Sep 20147:01 amRNSTotal Voting Rights
19th Sep 20147:00 amRNSAnnual Report and Accounts
15th Sep 201412:25 pmRNSDirector/PDMR Shareholding
11th Sep 20143:24 pmRNSDate of Payments to Shareholders
10th Sep 20147:00 amRNSFinal Results
15th Jul 20147:00 amRNSAppointment of new Executive Director
8th Jul 20145:00 pmRNSHolding(s) in Company
30th Jun 20147:00 amRNSTrading Update
2nd Jun 20143:06 pmRNSIssue of B class shares & Total Voting Rights
29th May 20144:32 pmRNSHolding(s) in Company
29th May 20143:50 pmRNSHolding(s) in Company
25th Apr 201412:40 pmRNSHolding(s) in Company
15th Apr 201410:04 amRNSHolding(s) in Company
14th Apr 20149:10 amRNSHolding(s) in Company
9th Apr 20147:00 amRNSCompletion of Refinancing
8th Apr 20144:40 pmRNSDirector/PDMR Shareholding
7th Apr 201411:17 amRNSDirector/PDMR Shareholding
4th Apr 20143:02 pmRNSDirector/PDMR Shareholding
18th Mar 20149:16 amRNSHolding(s) in Company
10th Mar 20144:59 pmRNSDirector Declaration
14th Feb 20149:27 amRNSHolding(s) in Company
11th Feb 20147:00 amRNSForthcoming Directorate Change
11th Feb 20147:00 amRNSHalf Yearly Report
9th Jan 20147:00 amRNSTrading Update
20th Dec 20132:53 pmRNSHolding(s) in Company
20th Dec 20131:29 pmRNSHolding(s) in Company
9th Dec 20138:36 amRNSHolding(s) in Company
3rd Dec 201310:13 amRNSHolding(s) in Company
2nd Dec 20134:31 pmRNSIssue of B Shares
1st Nov 20134:31 pmRNSHolding(s) in Company
1st Nov 20138:47 amRNSHolding(s) in Company
18th Oct 201312:58 pmRNSHolding(s) in Company
15th Oct 201311:24 amRNSResult of AGM
14th Oct 20137:00 amRNSAGM and Interim Management Statement
11th Oct 20139:19 amRNSChange of Registered Office
17th Sep 20133:41 pmRNSDirector/PDMR Shareholding
13th Sep 20139:03 amRNSAnnual Report and Accounts
13th Sep 20139:03 amRNSTotal Voting Rights
4th Sep 20138:56 amRNSDirector/PDMR Shareholding
3rd Sep 20137:00 amRNSFinal Results
5th Jul 20137:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.